Project Number 5P01AG002219-28 Agency/Funding Organization NIA Funding Year 2008 View Full Project Details for HYPERCHOLESTEROLEMIA AND ALZHEIMER'S DISEASE NEUROBIOLOGY Research Categorization Primary Disease / Condition Alzheimer's Disease Vascular Dementia/Dysfunction CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 5. Re-Purposed Biomarkers a. Cardiovascular Researcher and Organization Principal Investigator BUXBAUM, JOSEPH D. Principal Investigator First Name JOSEPH D. Principal Investigator Last Name BUXBAUM Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail FY Overall Cost $314,368 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [AlzPED] Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.